Author
@patientinvestor patientinvestor
grade Bx.com/patientinvestor ↗
Disciplined value screener surfacing high-ROIC compounders cheap on fundamentals
Posts quantified valuation/quality screens and reasoned long
trader score
+0.33
hit rate
60%
mean α
+0.13%
signals 14d
47
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Across their last 20 scored bets: 60% hit rate, +0.13% mean alpha, trader score +0.33. Their last-14d mentions, direction-adjusted, have moved -1.3% since posting (mean over 36 mentions with price data).
Recent signals15receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-08-28 | · | @patientinvestor | · | Uses Peter Lynch's premature sales to argue that price alone is not an investment thesis. | · | tweet ↗ |
| 2026-08-28 | · | @patientinvestor | · | Attributes a market pop to hedges, falling implied volatility, and market-maker share buying before traders sold. | · | tweet ↗ |
| 2026-08-28 | NVDA | @patientinvestor | +0.65 | Argues Nvidia remains near the low end of its AI-era valuation range despite an 8% rise. | — | tweet ↗ |
| 2026-08-28 | CSU.TO | @patientinvestor | +0.45 | Calls Topicus a compounding machine despite an unattractive chart, emphasizing business quality. | · | tweet ↗ |
| 2026-08-28 | TOI.V | @patientinvestor | +0.75 | Calls Topicus a compounding machine despite an unattractive chart, emphasizing business quality. | · | tweet ↗ |
| 2026-08-27 | PYPL | @patientinvestor | +0.70 | Argues PayPal's low earnings multiple makes another acquisition attempt likely if Stripe does not buy it. | -12.7% | tweet ↗ |
| 2026-08-27 | NKE | @patientinvestor | -0.55 | A $10,000 NKE investment ten years ago would now be worth only $7,500. | +3.0% | tweet ↗ |
| 2026-08-27 | MSFT | @patientinvestor | +0.00 | Lists forward P/E multiples for six major technology companies. | +1.7% | tweet ↗ |
| 2026-08-27 | AAPL | @patientinvestor | +0.00 | Lists forward P/E multiples for six major technology companies. | +1.6% | tweet ↗ |
| 2026-08-27 | NVDA | @patientinvestor | +0.00 | Lists forward P/E multiples for six major technology companies. | -4.6% | tweet ↗ |
| 2026-08-27 | AMZN | @patientinvestor | +0.00 | Lists forward P/E multiples for six major technology companies. | +4.0% | tweet ↗ |
| 2026-08-27 | AVGO | @patientinvestor | +0.00 | Lists forward P/E multiples for six major technology companies. | -0.7% | tweet ↗ |
| 2026-08-27 | GOOGL | @patientinvestor | +0.00 | Lists forward P/E multiples for six major technology companies. | +1.7% | tweet ↗ |
| 2026-08-26 | NVDA | @patientinvestor | -0.20 | States that market pricing reflects further deceleration in Nvidia EPS growth. | +3.8% | tweet ↗ |
| 2026-08-26 | · | @patientinvestor | · | Warns that buying solely on a low P/E can be dangerous in the wrong market cycle. | · | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.